Jeppe Ragnar Andersen

Chief Executive Officer
Management
Nordic Bioscience
Denmark

Business Expert Nephrology
Biography

 Jeppe Ragnar Andersen joined Nordic Bioscience in 2007 and became Head of Clinical Development in 2010. Jeppe has been CEO of Nordic Bioscience Clinical Development A/S since January 2014.  Jeppe is actively doing research into clinical trial methodology with a special focus on implementing risk-based monitoring and cost-benefit optimization. Over the years, Jeppe has been involved on an operational and executive level in numerous clinical studies with more than 15,000 patients within the therapeutic fields of osteoporosis, osteoarthritis and diabetes. 

Research Intrest

 Osteoporosis, osteoarthritis and diabetes.